BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14720323)

  • 1. Inhibition of lymphangiogenesis-related properties of murine lymphatic endothelial cells and lymph node metastasis of lung cancer by the matrix metalloproteinase inhibitor MMI270.
    Nakamura ES; Koizumi K; Kobayashi M; Saiki I
    Cancer Sci; 2004 Jan; 95(1):25-31. PubMed ID: 14720323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma.
    Zhang B; Wang J; Gao J; Guo Y; Chen X; Wang B; Gao J; Rao Z; Chen Z
    J Cell Biochem; 2009 May; 107(1):134-43. PubMed ID: 19241443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model.
    Wen J; Fu AF; Chen LJ; Xie XJ; Yang GL; Chen XC; Wang YS; Li J; Chen P; Tang MH; Shao XM; Lu Y; Zhao X; Wei YQ
    Int J Cancer; 2009 Jun; 124(11):2709-18. PubMed ID: 19219913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-metastatic and anti-angiogenic activities of a new matrix metalloproteinase inhibitor, TN-6b.
    Lee SJ; Sakurai H; Oshima K; Kim SH; Saiki I
    Eur J Cancer; 2003 Jul; 39(11):1632-41. PubMed ID: 12855272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophages induce capillary morphogenesis of lymphatic endothelial cells derived from human gastric cancer.
    Tauchi Y; Tanaka H; Kumamoto K; Tokumoto M; Sakimura C; Sakurai K; Kimura K; Toyokawa T; Amano R; Kubo N; Muguruma K; Yashiro M; Maeda K; Ohira M; Hirakawa K
    Cancer Sci; 2016 Aug; 107(8):1101-9. PubMed ID: 27227358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis.
    Karpinich NO; Kechele DO; Espenschied ST; Willcockson HH; Fedoriw Y; Caron KM
    FASEB J; 2013 Feb; 27(2):590-600. PubMed ID: 23099649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
    Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
    Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer.
    Xu J; Zhang C; He Y; Wu H; Wang Z; Song W; Li W; He W; Cai S; Zhan W
    Int J Cancer; 2012 Feb; 130(4):787-97. PubMed ID: 21387301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deguelin--an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model.
    Hu J; Ye H; Fu A; Chen X; Wang Y; Chen X; Ye X; Xiao W; Duan X; Wei Y; Chen L
    Int J Cancer; 2010 Nov; 127(10):2455-66. PubMed ID: 20162567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Horizontal transfer of exosomal CXCR4 promotes murine hepatocarcinoma cell migration, invasion and lymphangiogenesis.
    Li M; Lu Y; Xu Y; Wang J; Zhang C; Du Y; Wang L; Li L; Wang B; Shen J; Tang J; Song B
    Gene; 2018 Nov; 676():101-109. PubMed ID: 30010038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells.
    Tai HC; Lee TH; Tang CH; Chen LP; Chen WC; Lee MS; Chen PC; Lin CY; Chi CW; Chen YJ; Lai CT; Chen SS; Liao KW; Lee CH; Wang SW
    Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30959907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer.
    Janowska-Wieczorek A; Wysoczynski M; Kijowski J; Marquez-Curtis L; Machalinski B; Ratajczak J; Ratajczak MZ
    Int J Cancer; 2005 Feb; 113(5):752-60. PubMed ID: 15499615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
    Hwang-Bo J; Bae MG; Park JH; Chung IS
    BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
    BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor angiogenic effect of a matrix metalloproteinase inhibitor MMI270.
    Nakamura ES; Koizumi K; Yamaura T; Saiki I
    Anticancer Res; 2003; 23(1A):411-7. PubMed ID: 12680241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor-bearing mice.
    Huang TH; Chiu YH; Chan YL; Chiu YH; Wang H; Huang KC; Li TL; Hsu KH; Wu CJ
    Mar Drugs; 2015 Apr; 13(4):1882-900. PubMed ID: 25854641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.